Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Research and Markets
DUBLIN, Aug. 19, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Human Growth Hormone Drugs - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Human Growth Hormone Drugs in US$ Million by the following Brands: Humatrope, Norditropin, Genotropin, Nutropin, Saizen, and Others.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets.
Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 30 companies including many key and niche players such as:
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW
2. MARKET TRENDS & ISSUES
4. HUMAN GROWTH HORMONE: AN OVERVIEW
5. RECENT INDUSTRY ACTIVITY
6. FOCUS ON SELECT GLOBAL PLAYERS
7. GLOBAL MARKET PERSPECTIVE
1. THE UNITED STATES
6. REST OF WORLD
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 30 (including Divisions/Subsidiaries 33)
For more information visit http://www.researchandmarkets.com/research/3r8dfr/human_growth
Media Contact: Laura Wood, +353-1-481-1716, email@example.com
©2012 PR Newswire. All Rights Reserved.